These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3050086)
1. Clinical trials with biological response modifiers in rheumatic diseases. Scheinberg MA J Rheumatol; 1988 Jul; 15(7):1056-7. PubMed ID: 3050086 [No Abstract] [Full Text] [Related]
2. [Prospects of the use of cyclosporin A in rheumatic diseases]. Nasonov EL; Shtutman VZ; Nasonova VA Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807 [No Abstract] [Full Text] [Related]
3. [Controlled clinical research on the use of ibuprofen in rheumatoid arthritis and other rheumatic diseases]. Giordano M; Tirri G; Capelli L; Gallo M; Scott GG Minerva Med; 1973 Jun; 64(47):2483-90. PubMed ID: 4579840 [No Abstract] [Full Text] [Related]
4. [Clinical study with a new phenylbutazone preparation in rheumatology]. Marmont A; Rossi F Clin Ter; 1972 Oct; 63(1):17-51. PubMed ID: 4566104 [No Abstract] [Full Text] [Related]
6. [Indomethacin in rheumatic diseases with special reference to ophthalmologic studies]. Klein G; Fellner S; Fellner R Med Klin; 1972 Feb; 67(8):250-4. PubMed ID: 4555586 [No Abstract] [Full Text] [Related]
7. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus. Goldblatt F; Isenberg DA Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946 [TBL] [Abstract][Full Text] [Related]
8. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Silverman GJ; Weisman S Arthritis Rheum; 2003 Jun; 48(6):1484-92. PubMed ID: 12794814 [No Abstract] [Full Text] [Related]
10. [Experience in using indocide in the treatment of rheumatic diseases]. Berovich Z; Nikolich Iu; Budimir M Vopr Revm; 1970; 10(2):34-8. PubMed ID: 5312303 [No Abstract] [Full Text] [Related]
11. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk? Molloy ES; Calabrese LH Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172 [TBL] [Abstract][Full Text] [Related]
12. Systemic corticosteroid therapy in rheumatic diseases. Fries JF; McDevitt HO Ration Drug Ther; 1972 Nov; 6(11):1-5. PubMed ID: 4147211 [No Abstract] [Full Text] [Related]
13. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. Eisenberg R; Albert D Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648 [TBL] [Abstract][Full Text] [Related]
14. B cell depletion therapy in rheumatic disease. Edwards JC; Cambridge G; Leandro MJ Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):915-28. PubMed ID: 16980214 [TBL] [Abstract][Full Text] [Related]
15. Biological Response Modifiers Programme and cancer chemotherapy. Oldham RK Int J Tissue React; 1982; 4(3):173-88. PubMed ID: 6183193 [TBL] [Abstract][Full Text] [Related]
16. The role of therapeutic plasmapheresis in the rheumatic diseases. Jones JV; Clough JD; Klinenberg JR; Davis P J Lab Clin Med; 1981 May; 97(5):589-98. PubMed ID: 6452484 [No Abstract] [Full Text] [Related]
17. [Our experiences with immunosuppressive therapy of rheumatic diseases]. Malesević M; Andelić M; Nakicević M; Pasić I Med Arh; 1974 Jan; 28(0):suppl:65-9. PubMed ID: 4600455 [No Abstract] [Full Text] [Related]
18. [Antimalarial agents in rheumatic diseases. New therapeutic aspects of an old medication]. Barthel HR; Meier LG; Wallace DJ Dtsch Med Wochenschr; 1996 Dec; 121(50):1576-82. PubMed ID: 8998931 [No Abstract] [Full Text] [Related]
19. [Immunosuppressive treatment in rheumatology]. Menkes CJ Cah Med; 1971 Dec; 12(16):1391-8. PubMed ID: 5316944 [No Abstract] [Full Text] [Related]
20. [Aspirin in the treatment of inflammatory rheumatism in 1987]. Cohen de Lara A Rev Prat; 1987 Oct; 37(41):2493-9. PubMed ID: 3500497 [No Abstract] [Full Text] [Related] [Next] [New Search]